Studies on trypsin treatment of red cells with special reference to differences between trypsin preparations.
D000918:Antibody Specificity; D001963:Bromelains / Q000494:pharmacology; D002021:Buffers; D004912:Erythrocytes / Q000187:drug effects*; D006386:Hemagglutination Tests; D006460:Hemolysin Proteins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007106:Immune Sera; D010206:Papain / Q000494:pharmacology; D012204:Rh-Hr Blood-Group System / Q000032:analysis; D014357:Trypsin / Q000494:pharmacology* / Q000592:standards; D014361:Trypsin Inhibitors
D002021:Buffers; D006460:Hemolysin Proteins; D007106:Immune Sera; D012204:Rh-Hr Blood-Group System; D014361:Trypsin Inhibitors; D001963:Bromelains; D014357:Trypsin; D010206:Papain